A novel nonviral gene delivery system for treating Leber's congenital amaurosis
2017; Future Science Ltd; Volume: 8; Issue: 10 Linguagem: Inglês
10.4155/tde-2017-0072
ISSN2041-6008
AutoresDa Sun, Rebecca M. Schur, Zheng‐Rong Lu,
Tópico(s)Ocular Disorders and Treatments
ResumoTherapeutic DeliveryVol. 8, No. 10 CommentaryA novel nonviral gene delivery system for treating Leber's congenital amaurosisDa Sun, Rebecca M Schur & Zheng-Rong LuDa Sun Case Center for Biomolecular Engineering, Department of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, OH 44106, USA, Rebecca M Schur Case Center for Biomolecular Engineering, Department of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, OH 44106, USA & Zheng-Rong Lu*Author for correspondence: Tel.: +1 216 368 0187; E-mail Address: zxl125@case.edu Case Center for Biomolecular Engineering, Department of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, OH 44106, USA M. Frank Rudy & Margaret Domiter Rudy Professor of Biomedical Engineering, Department of Biomedical Engineering, Case Western Reserve University, Wickenden 427, Mail Stop 7207, 10900 Euclid Avenue, Cleveland, OH 44106, USAPublished Online:25 Sep 2017https://doi.org/10.4155/tde-2017-0072AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: ECOgene therapyLCAnanoparticlenonviralretinaRPE65References1 Stone EM. Leber congenital amaurosis – a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson memorial lecture. Am. J. Ophthalmol. 144(6), 791–811.e796 (2007).Crossref, Medline, CAS, Google Scholar2 Kiser PD, Zhang J, Badiee M et al. Catalytic mechanism of a retinoid isomerase essential for vertebrate vision. Nat. Chem. Biol. 11(6), 409–415 (2015).Crossref, Medline, CAS, Google Scholar3 Aguirre GD, Baldwin V, Pearce-Kelling S, Narfström K, Ray K, Acland GM. Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect. Mol. Vis. 4, 23 (1998).Medline, CAS, Google Scholar4 Jacobson SG, Cideciyan AV, Ratnakaram R et al. Gene therapy for leber congenital amaurosis caused by rpe65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch. Ophthalmol. 130(1), 9–24 (2012).Crossref, Medline, CAS, Google Scholar5 Bennett J. Taking stock of retinal gene therapy: looking back and moving forward. Mol. Ther. 25(5), 1076–1094 (2017).Crossref, Medline, CAS, Google Scholar6 Narfström K, Katz ML, Bragadottir R et al. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Invest. Ophthalmol. Vis. Sci. 44(4), 1663–1672 (2003).Crossref, Medline, Google Scholar7 Fraser Wright J, Wellman J, High KA. Manufacturing and regulatory strategies for clinical AAV2-hRPE65. Curr. Gene Ther. 10(5), 341–349 (2010).Crossref, Medline, Google Scholar8 Colella P, Cotugno G, Auricchio A. Ocular gene therapy: current progress and future prospects. Trends Mol. Med. 15(1), 23–31 (2009).Crossref, Medline, CAS, Google Scholar9 Rivera A, White K, Stöhr H et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am. J. Hum. Genet. 67(4), 800–813 (2000).Crossref, Medline, CAS, Google Scholar10 Eudy JD, Weston MD, Yao S et al. Mutation of a gene encoding a protein with extracellular matrix motifs in usher syndrome type IIa. Science 280(5370), 1753–1757 (1998).Crossref, Medline, CAS, Google Scholar11 Guo S, Huang L. Nanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapy. J. Nanomaterials 2011, 1–12 (2011).Medline, Google Scholar12 Horbinski C, Stachowiak MK, Higgins D, Finnegan SG. Polyethyleneimine-mediated transfection of cultured postmitotic neurons from rat sympathetic ganglia and adult human retina. BMC Neurosci. 2(1), 2 (2001).Crossref, Medline, CAS, Google Scholar13 Rajala A, Wang Y, Zhu Y et al. Nanoparticle-assisted targeted delivery of eye-specific genes to eyes significantly improves the vision of blind mice in vivo. Nano Lett. 14(9), 5257–5263 (2014).Crossref, Medline, CAS, Google Scholar14 De La Fuente M, Raviña M, Paolicelli P, Sanchez A, Seijo B, Alonso MJ. Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv. Drug Deliv. Rev. 62(1), 100–117 (2010).Crossref, Medline, CAS, Google Scholar15 Zhou X-Y, Liao Q, Pu Y-M et al. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization. Chin. Med. J. (Engl.) 122(22), 2711–2717 (2009).Medline, CAS, Google Scholar16 Koirala A, Makkia RS, Conley SM, Cooper MJ, Naash MI. S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA. Hum. Mol. Genet. 22(8), 1632–1642 (2013).Crossref, Medline, CAS, Google Scholar17 Malamas AS, Gujrati M, Kummitha CM, Xu R, Lu Z-R. Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery. J. Control. Rel. 171(3), 296–307 (2013).Crossref, Medline, CAS, Google Scholar18 Gujrati M, Malamas A, Shin T, Jin E, Sun Y, Lu Z-R. Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release. Mol. Pharm. 11(8), 2734–2744 (2014).Crossref, Medline, CAS, Google Scholar19 Parvani JG, Gujrati MD, Mack MA, Schiemann WP, Lu Z-R. Silencing β3 integrin by targeted ECO/siRNA nanoparticles inhibits EMT and metastasis of triple-negative breast cancer. Cancer Res. 75(11), 2316–2325 (2015).Crossref, Medline, CAS, Google Scholar20 Sun D, Sahu B, Gao S et al. Targeted multifunctional lipid ECO plasmid DNA nanoparticles as efficient nonviral gene therapy for Leber's congenital amaurosis. Mol. Ther. Nucleic Acids. 7, 42–52 (2017).Crossref, Medline, CAS, Google Scholar21 Sun D, Maeno H, Gujrati M et al. Self-assembly of a multifunctional lipid with core-shell dendrimer DNA nanoparticles enhanced efficient gene delivery at low charge ratios into RPE cells. Macromol. Biosci. 15(12), 1663–1672 (2015).Crossref, Medline, CAS, Google Scholar22 Gujrati M, Vaidya A, Lu Z-R. Multifunctional pH-sensitive amino lipids for siRNA delivery. Bioconjug. Chem. 27(1), 19–35 (2016).Crossref, Medline, CAS, Google Scholar23 Gujrati M, Vaidya AM, Mack M, Snyder D, Malamas A, Lu Z-R. Targeted dual pH-sensitive lipid ECO/siRNA self-assembly nanoparticles facilitate in vivo cytosolic sieIF4E delivery and overcome paclitaxel resistance in breast cancer therapy. Adv. Healthc. Mater. 5(22), 2882–2895 (2016).Crossref, Medline, CAS, Google Scholar24 Veldman GM, Lupton S, Kamen R. Polyomavirus enhancer contains multiple redundant sequence elements that activate both DNA replication and gene expression. Mol. Cell Biol. 5(4), 649–658 (1985).Crossref, Medline, CAS, Google Scholar25 Mussolino C, Della Corte M, Rossi S et al. AAV-mediated photoreceptor transduction of the pig cone-enriched retina. Gene Ther. 18(7), 637–645 (2011).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByDirecting the Way—Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery15 September 2022 | Pharmaceutical Research, Vol. 40, No. 1Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid Delivery4 January 2023 | Pharmaceutical Research, Vol. 40, No. 1Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse modelJournal of Controlled Release, Vol. 330Dramatic influence of the hydroxy functionality of azasugar moiety in the head group region of tocopherol-based cationic lipids on in vitro gene transfection efficacies1 January 2021 | New Journal of Chemistry, Vol. 45, No. 2Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled NanoparticlesMolecular Therapy, Vol. 28, No. 1Synthesis and Evaluation of pH-Sensitive Multifunctional Lipids for Efficient Delivery of CRISPR/Cas9 in Gene Editing24 December 2018 | Bioconjugate Chemistry, Vol. 30, No. 3 Vol. 8, No. 10 Follow us on social media for the latest updates Metrics Downloaded 73 times History Published online 25 September 2017 Published in print October 2017 Information© 2017 Future Science LtdKeywordsECOgene therapyLCAnanoparticlenonviralretinaRPE65Financial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download
Referência(s)